Nagaoki, Y.; Yamaoka, K.; Fujii, Y.; Uchikawa, S.; Fujino, H.; Ono, A.; Murakami, E.; Kawaoka, T.; Miki, D.; Aikata, H.;
et al. Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals. Livers 2024, 4, 352-363.
https://doi.org/10.3390/livers4030025
AMA Style
Nagaoki Y, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Ono A, Murakami E, Kawaoka T, Miki D, Aikata H,
et al. Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals. Livers. 2024; 4(3):352-363.
https://doi.org/10.3390/livers4030025
Chicago/Turabian Style
Nagaoki, Yuko, Kenji Yamaoka, Yasutoshi Fujii, Shinsuke Uchikawa, Hatsue Fujino, Atsushi Ono, Eisuke Murakami, Tomokazu Kawaoka, Daiki Miki, Hiroshi Aikata,
and et al. 2024. "Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals" Livers 4, no. 3: 352-363.
https://doi.org/10.3390/livers4030025
APA Style
Nagaoki, Y., Yamaoka, K., Fujii, Y., Uchikawa, S., Fujino, H., Ono, A., Murakami, E., Kawaoka, T., Miki, D., Aikata, H., Hayes, C. N., Tsuge, M., & Oka, S.
(2024). Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals. Livers, 4(3), 352-363.
https://doi.org/10.3390/livers4030025
